| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2008, p. 2653-2656, Vol. 52, No. 7
0066-4804/08/$08.00+0 doi:10.1128/AAC.01329-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510663, China
Received 16 October 2007/ Returned for modification 7 January 2008/ Accepted 21 April 2008
The synergy of the activities between chloroquine and various human immunodeficiency virus protease inhibitors was investigated in chloroquine-resistant and -sensitive malaria parasites. In both in vitro and in vivo assay systems, ritonavir was found to be the most potent in potentiating the antimalarial action of chloroquine.
Published ahead of print on 28 April 2008.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |